Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cyclosporine A vs Fluorometholone for SEIs in EKC
NCT04376970Phase 4Completed
- Sponsor
- Military Hospital of Tunis
- Start
- Apr 2017
- Primary completion
- Apr 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of cyclosporine 2% ophthalmic solution in epidemic keratoconjunctivitis (EKC), sponsored by Military Hospital of Tunis. Started Apr 2017; status: completed.
02
Drugs
cyclosporine 2% ophthalmic solution
03
Conditions
epidemic keratoconjunctivitis (EKC)
Beyond the preview
Go deeper on NCT04376970.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04376970.